Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021227

Expand all

CANCIDAS (CASPOFUNGIN ACETATE)
50MG/VIAL
Marketing Status: Prescription

Active Ingredient: CASPOFUNGIN ACETATE
Proprietary Name: CANCIDAS
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N021227
Product Number: 001
Approval Date: Jan 26, 2001
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CANCIDAS (CASPOFUNGIN ACETATE)
70MG/VIAL
Marketing Status: Prescription

Active Ingredient: CASPOFUNGIN ACETATE
Proprietary Name: CANCIDAS
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 70MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N021227
Product Number: 002
Approval Date: Jan 26, 2001
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information